Profil
Fu Ling Yeh is currently the Chairman at CTY Ventures.
She is also an Independent Director at Tainergy Tech Co., Ltd. and a Director at Cellusion Inc. In the past, she worked as a Member-Supervisory Board at Lumitek Corp.
Ms. Yeh holds an MBA from the University of Pittsburgh and a graduate degree from the University of Pennsylvania.
Postes actifs de Fu Ling Yeh
| Sociétés | Poste | Début |
|---|---|---|
| TAINERGY TECH CO., LTD. | Directeur/Membre du Conseil | 28/04/2010 |
CTY Ventures
CTY Ventures Investment ManagersFinance Operates as a venture capital firm | Président | - |
Cellusion Inc.
Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Engages in regenerating corneal endothelium using IPS cells for treatment of bullous keratopathy | Directeur/Membre du Conseil | - |
Anciens postes connus de Fu Ling Yeh
| Sociétés | Poste | Fin |
|---|---|---|
Lumitek Corp.
Lumitek Corp. SemiconductorsElectronic Technology Manufactures light emitting diode chip | Directeur/Membre du Conseil | - |
Formation de Fu Ling Yeh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumitek Corp.
Lumitek Corp. SemiconductorsElectronic Technology Manufactures light emitting diode chip | Electronic Technology |
Tainergy Tech Co., Ltd.
Tainergy Tech Co., Ltd. SemiconductorsElectronic Technology Designs, develops, manufactures and markets high-performance solar cells | Electronic Technology |
CTY Ventures
CTY Ventures Investment ManagersFinance Operates as a venture capital firm | Finance |
Cellusion Inc.
Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Engages in regenerating corneal endothelium using IPS cells for treatment of bullous keratopathy | Commercial Services |
















